The Canadian cannabis producer that was in talks with Coca-Cola to make a CBD-infused drink is reportedly targeting a US IPO in October

Cannabis, Life Science

China Medical In-Licenses China Rights to VAXIMM’s Immunotherapies

Life Science

Innovent’s PD-1 Candidate Effective Against NSCLC; Will Start Phase III Trial

Life Science

Beijing’s Hillhouse Closes Latest Fund with $10.6 Billion, a Record

Life Science

Life Science & Technology Weekly 161 – Chinese Plastic Surgery Chain BeauCare Clinics Raises $58M Series C Round From Sino-Ocean Capital

Life Science, Technology

Pot-focused investment fund backed by Peter Thiel gets a boost from its big stake in Tilray

Cannabis, Life Science

UTILITY Receives Investigational New Drug Approval from US FDA

Life Science

Galera Therapeutics Nabs $150 Million to Drive Lead Therapeutic Into Phase III

Life Science

WuXi AppTec Files for $1 Billion-Plus IPO in Hong Kong

Life Science

China News Weekly 78 – China’s Sinopec plans to build Canadian oil refinery

Energy, Life Science, Technology

Chinese Plastic Surgery Chain BeauCare Clinics Raises $58M Series C Round From Sino-Ocean Capital

Life Science

General Atlantic Invests $150 Million in Asia Holding, a Hospital/Clinic Company

Life Science

Digital China Health to Promote Genomics Diagnostic Support System in China

Life Science

Coca-Cola looks at marijuana ingredient cannabidiol in ‘wellness beverages’

Cannabis, Life Science

AstraZeneca Plans to Seek Regulatory Approval for COPD Drug PT010 Following Phase III Trial

Life Science